Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: nucleic acid therapeutics - KAN Research Institute

Next Previous
Search
Drug Profile

Research programme: nucleic acid therapeutics - KAN Research Institute

Latest Information Update: 28 Jul 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator KAN Research Institute
  • Class Nucleic acids
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Unspecified

Most Recent Events

  • 28 Jul 2022 No recent reports of development identified for research development in Unspecified in Japan
  • 14 Jun 2018 KAN Research Institute, Osaka University, The National Institute of Biomedical Innovation, Health and Nutrition, GeneDesign, Tokyo Women’s Medical University and The National Cancer Center Hospital East enter into an industry-academia-government collaboration to develop nucleic acid therapeutics using novel nucleic acid synthesis and delivery technologies
  • 13 Jun 2018 Early research in Undefined indication in Japan (unspecified route)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top